1. Home
  2. NVDA vs NVO Comparison

NVDA vs NVO Comparison

Compare NVDA & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVIDIA Corporation

NVDA

NVIDIA Corporation

N/A

Current Price

$212.25

Market Cap

4.9T

Sector

Technology

ML Signal

N/A

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

N/A

Current Price

$42.48

Market Cap

199.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NVDA
NVO
Founded
1993
1923
Country
United States
Denmark
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9T
199.4B
IPO Year
1998
2001

Fundamental Metrics

Financial Performance
Metric
NVDA
NVO
Price
$212.25
$42.48
Analyst Decision
Strong Buy
Hold
Analyst Count
38
11
Target Price
$266.24
$51.00
AVG Volume (30 Days)
112.2M
9.3M
Earning Date
05-20-2026
05-06-2026
Dividend Yield
0.02%
3.19%
EPS Growth
66.67
N/A
EPS
4.85
N/A
Revenue
$215,938,000,000.00
N/A
Revenue This Year
$73.22
N/A
Revenue Next Year
$31.16
$3.70
P/E Ratio
$45.04
$13.60
Revenue Growth
65.47
N/A
52 Week Low
$164.27
$35.12
52 Week High
$236.54
$64.16

Technical Indicators

Market Signals
Indicator
NVDA
NVO
Relative Strength Index (RSI) 42.84 38.68
Support Level $208.02 $43.29
Resistance Level $214.98 $48.15
Average True Range (ATR) 5.94 0.87
MACD -1.32 -0.28
Stochastic Oscillator 1.61 13.98

Price Performance

Historical Comparison
NVDA
NVO

About NVDA NVIDIA Corporation

Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence to run large language models. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: